Home > Journals > International Angiology > Past Issues > International Angiology 2005 September;24(3)


A Journal on Angiology

Official Journal of the International Union of Angiology, the International Union of Phlebology and the Central European Vascular Forum
Indexed/Abstracted in: BIOSIS Previews, Current Contents/Clinical Medicine, EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,37

Frequency: Bi-Monthly

ISSN 0392-9590

Online ISSN 1827-1839



International Angiology 2005 September;24(3)


International Angiology 2005 September;24(3):207-14

Glucose intolerance: the hidden danger in hypertensives!

Salmasi A. M., Dancy M.


International Angiology 2005 September;24(3):215-20

The biological role of protease-activated receptors in angiology. The present view

Skórkowska K., Adamiec R.


International Angiology 2005 September;24(3):221-30

Factors associated with mortality in patients with asymptomatic carotid stenosis: results from the ACSRS Study

Kakkos S. K., Nicolaides A., Griffin M., Sabetai M., Dhanjil S., Thomas D. J., Sonecha T., Salmasi A. M., Geroulakos G., Georgiou N., Francis S., Ioannidou E., Dore C. J., for the Asymptomatic Carotid Stenosis and Risk of Stroke (ACSRS) Study Group


International Angiology 2005 September;24(3):231-7

Recovery following treatment of descending thoracic aortic disease. A comparison between endovascular repair and open surgery

Aasland J., Lundbom J., Eide T. O., Ødegård A., Aadahl P., Romundstad P. R., Myhre H. O.


International Angiology 2005 September;24(3):238-44

Mini-laparotomy for repair of infrarenal abdominal aortic aneurysm

Laohapensang K., Rerkasem K., Chotirosniramit N.


International Angiology 2005 September;24(3):245-9

The impact of comorbidity on long-term results of above-knee prosthetic femoropopliteal bypass for intermittent claudication

Pedersen G., Laxdal E., Hagala M., Aune S.


International Angiology 2005 September;24(3):250-4

Risk assessment model for venothromboembolism in post-hospitalized patients

Yale S. H., Medlin S. C., Liang H., Peters T., Glurich I., Mazza J. J.


International Angiology 2005 September;24(3):255-7

Are we managing primary upper limb deep venous thrombosis aggressively enough in the district?

Fassiadis N., Roidl M., South M.


International Angiology 2005 September;24(3):258-64

Chronic venous disease: health status of a population and care impact on this health status through quality of life questionnaires

Guex J. J., Myon E., Didier L., Nguyen Le C., Taieb C.


International Angiology 2005 September;24(3):265-71

Venous disease and ergonomics of female employment

Allaert F. A., Cazaubon M., Causse C., Lecomte Y., Urbinelli R.


International Angiology 2005 September;24(3):272-7

Quality of life in chronic venous insufficiency. An Italian pilot study of the Triveneto Region

Andreozzi G. M., Cordova R., Scomparin M. A., Martini R., D’Eri A., Andreozzi F.


International Angiology 2005 September;24(3):278-81

Elevation of plasma von Willebrand factor and tumor necrosis factor-a in obese subjects and their reduction by the low molecular weight heparin tinzaparin

Mousa S. A.


International Angiology 2005 September;24(3):282-6

Long-term results of treatments for varicose veins due to greater saphenous vein insufficiency

Miyazaki K., Nishibe T., Sata F., Murashita T., Kudo F. A., Miyazaki Y. J., Nishibe M., Ando M., Yasuda K.


International Angiology 2005 September;24(3):287-94

The MTHFR 677TT and 677CT/1298AC genotypes in Cypriot patients may be predisposing to hypertensive nephrosclerosis and chronic renal failure

Koupepidou P., Deltas C., Christofides T. C., Athanasiou Y., Zouvani I., Pierides A.


International Angiology 2005 September;24(3):295-9

Non invasive evaluation of endothelial function in patients with Anderson-Fabry disease

Puccio D., Coppola G., Corrado E., Muratori I., Pistone G., Buongiorno M. R., Aricò M., Novo S.


International Angiology 2005 September;24(3):300-3

Matrix metalloproteinases in isolated hypercholesterolemia

Malik J., Stulc T., Ceska R.


International Angiology 2005 September;24(3):304-7

Refractory Takayasu’s arteritis successfully treated with the human, monoclonal anti-tumor necrosis factor antibody adalimumab


top of page